|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's range||49.92 - 50.30|
|52-week range||37.62 - 55.00|
|Beta (5Y monthly)||0.35|
|PE ratio (TTM)||25.88|
|Forward dividend & yield||1.70 (3.40%)|
|Ex-dividend date||30 Apr 2020|
|1y target est||61.38|
With three vaccine candidates out with a first look at efficacy data, Wall Street is more optimistic about the light at the end of the pandemic tunnel.
The European Commission nods to Sanofi's (SNY) MenQuadfi, a meningococcal vaccine for individuals, aged 12 months and older.
The EU is buying vaccines on behalf of 27 member states.